Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial (Q48580401)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

adaptive radiation therapy

0 references

phase III clinical trial

0 references

0 references

prostate cancer

1 reference

based on heuristic

inferred from title

12

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

object named as

Eleanor Walsh

4

0 references

object named as

Emma L Turner

7

0 references

object named as

Tim J Peters

10

0 references

Richard M Martin

object named as

Richard M Martin

11

0 references

0 references

Jenny L Donovan

2

object named as

Jenny L Donovan

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

13

object named as

Freddie C Hamdy

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

5

object named as

Daniel Dedman

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

ProtecT study group

14

object named as

ProtecT study group

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

author name string

J Athene Lane

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Michael Davis

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Liz Down

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Malcolm D Mason

8

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Chris Metcalfe

9

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

publication date

19 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

15

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

10

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

1109-1118

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus observation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Latest results from the UK trials evaluating prostate cancer screening and treatment: The CAP and ProtecT studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and preliminary recruitment results of the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development of a complex intervention improved randomization and informed consent in a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A Peer Review Intervention for Monitoring and Evaluating sites (PRIME) that improved randomized controlled trial conduct and performance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Implementing the UK Medical Research Council (MRC) RT01 trial (ISRCTN 47772397): methods and practicalities of a randomised controlled trial of conformal radiotherapy in men with localised prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of biochemical control and prognostic factors in patients treated with either low-dose three-dimensional conformal radiation therapy or high-dose intensity-modulated radiotherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality control of radical prostatectomy: a feasibility study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Sexual dysfunction in men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple testing in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incorporating prognostic factors into causal estimators: a comparison of methods for randomised controlled trials with a time-to-event outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A causal proportional hazards estimator for the effect of treatment actually received in a randomized trial with all-or-nothing compliance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results From a Prospective Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality improvement report: Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. Commentary: presenting unbiased information to patients can be diffic

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2814%2970361-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(14)70361-4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/25163905

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48580401&oldid=2202193652"